Several independent pharmacy owners told NBC News the drug is bad for business. Pharmacies pay about $900 for a 30-day supply but are typically reimbursed only $860, according to the report. The underpayments by pharmacy benefit managers can mean going out of business for some, one pharmacist said.
“There have been supply issues, but a lot of independents are just telling people we can’t get it because we can’t afford to dispense things below cost,” Steve Hoffart, PharmD, the owner of Magnolia (Texas) Pharmacy, told NBC News.
“These [payment] details are negotiated between pharmacies and external third parties,” Allison Schneider, a spokesperson for Novo Nordisk, which makes Ozempic, told NBC News. The manufacturer has no control over what pharmacies pay or what PBMs reimburse.
The drug’s popularity has recently soared, but ongoing shortages of Ozempic have led some diabetic patients to ration the medication. Despite the shortage, prescriptions have risen across the country.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
